676 related articles for article (PubMed ID: 9074532)
1. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease.
Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M
J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532
[TBL] [Abstract][Full Text] [Related]
2. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats.
Hatada K; Riou LM; Ruiz M; Yamamichi Y; Duatti A; Lima RL; Goode AR; Watson DD; Beller GA; Glover DK
J Nucl Med; 2004 Dec; 45(12):2095-101. PubMed ID: 15585487
[TBL] [Abstract][Full Text] [Related]
3. Comparative myocardial uptake of technetium-99 m sestamibi and technetium-99m tetrofosmin one hour after stress injection.
Gremillet E; Champailler A
Eur J Nucl Med; 1998 Nov; 25(11):1502-10. PubMed ID: 9799346
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi.
Flamen P; Bossuyt A; Franken PR
J Nucl Med; 1995 Nov; 36(11):2009-15. PubMed ID: 7472590
[TBL] [Abstract][Full Text] [Related]
5. Influence of the different biokinetics of sestamibi and tetrofosmin on the interpretation of myocardial perfusion imaging in daily practice.
Hambÿe AS; Delsarte P; Vervaet AM
Nucl Med Commun; 2007 May; 28(5):383-90. PubMed ID: 17414888
[TBL] [Abstract][Full Text] [Related]
6. Are technetium-99m-labeled myocardial perfusion agents adequate for detection of myocardial viability?
Caner B; Beller GA
Clin Cardiol; 1998 Apr; 21(4):235-42. PubMed ID: 9562932
[TBL] [Abstract][Full Text] [Related]
7. Efficiency comparison between 99m Tc-tetrofosmin and 99m Tc-sestamibi myocardial perfusion studies.
Ravizzini GC; Hanson MW; Shaw LK; Wong TZ; Hagge RJ; Pagnanelli RA; Jain D; Lima HS; Coleman RE; Borges-Neto S
Nucl Med Commun; 2002 Mar; 23(3):203-8. PubMed ID: 11891477
[TBL] [Abstract][Full Text] [Related]
8. Comparison of sestamibi, tetrofosmin, and Q12 retention in porcine myocardium.
Matsunari I; Haas F; Nguyen NT; Reidel G; Wolf I; Senekowitsch-Schmidtke R; Stöcklin G; Schwaiger M
J Nucl Med; 2001 May; 42(5):818-23. PubMed ID: 11337582
[TBL] [Abstract][Full Text] [Related]
9. Myocardial uptake characteristics of three 99mTc-labeled tracers for myocardial perfusion imaging one hour after rest injection.
Manka-Waluch A; Palmedo H; Reinhardt MJ; Joe AY; Manka C; Guhlke S; Biersack HJ; Bucerius J
Ann Nucl Med; 2006 Dec; 20(10):663-70. PubMed ID: 17385304
[TBL] [Abstract][Full Text] [Related]
10. Monocationic radiotracer kinetics and myocardial infarct size: a perfused rat heart study.
Okada DR; Liu Z; Beju D; Okada RD; Johnson G
Ann Nucl Med; 2008 Aug; 22(7):617-27. PubMed ID: 18756365
[TBL] [Abstract][Full Text] [Related]
11. Direct comparison of technetium 99m-sestamibi and technetium 99m-tetrofosmin cardiac single photon emission computed tomography in patients with coronary artery disease.
Acampa W; Cuocolo A; Sullo P; Varrone A; Nicolai E; Pace L; Petretta M; Salvatore M
J Nucl Cardiol; 1998; 5(3):265-74. PubMed ID: 9669581
[TBL] [Abstract][Full Text] [Related]
12. Technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells.
Arbab AS; Koizumi K; Toyama K; Arai T; Araki T
J Nucl Med; 1998 Feb; 39(2):266-71. PubMed ID: 9476934
[TBL] [Abstract][Full Text] [Related]
13. Myocardial tomography with technetium-99m-tetrofosmin during intravenous infusion of adenosine triphosphate.
Takeishi Y; Takahashi N; Fujiwara S; Atsumi H; Takahashi K; Tomoike H
J Nucl Med; 1998 Apr; 39(4):582-6. PubMed ID: 9544660
[TBL] [Abstract][Full Text] [Related]
14. Comparison of microsphere-equivalent blood flow (15O-water PET) and relative perfusion (99mTc-tetrofosmin SPECT) in myocardium showing metabolism-perfusion mismatch.
Schaefer WM; Nowak B; Kaiser HJ; Koch KC; Block S; vom Dahl J; Buell U
J Nucl Med; 2003 Jan; 44(1):33-9. PubMed ID: 12515874
[TBL] [Abstract][Full Text] [Related]
15. Organ biodistribution and myocardial uptake, washout, and redistribution kinetics of Tc-99m N-DBODC5 when injected during vasodilator stress in canine models of coronary stenoses.
Hatada K; Ruiz M; Riou LM; Lima RL; Goode AR; Watson DD; Beller GA; Glover DK
J Nucl Cardiol; 2006 Nov; 13(6):779-90. PubMed ID: 17174809
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia.
Sinusas AJ; Shi Q; Saltzberg MT; Vitols P; Jain D; Wackers FJ; Zaret BL
J Nucl Med; 1994 Apr; 35(4):664-71. PubMed ID: 8151391
[TBL] [Abstract][Full Text] [Related]
17. Uptake of 99mTc tetrofosmin in lymphoma cell lines: a comparative study with 99mTc sestamibi.
Ding HJ; Shiau YC; Tsai SC; Wang JJ; Ho ST; Kao A
Appl Radiat Isot; 2002 Jun; 56(6):853-6. PubMed ID: 12102342
[TBL] [Abstract][Full Text] [Related]
18. Assessment of 99Tcm-tetrofosmin lung uptake: a modified method to avoid the contribution from high chest wall activity.
Heiba SI; Ziada G; Higazy E; Saleh M; Elgazzar AH
Nucl Med Commun; 1998 Sep; 19(9):859-66. PubMed ID: 10581592
[TBL] [Abstract][Full Text] [Related]
19. Outcome prediction in patients at high risk for coronary artery disease: comparison between 99mTc tetrofosmin and 99mTc sestamibi.
Borges-Neto S; Tuttle RH; Shaw LK; Smith WT; Jain D; Coleman RE; Whellan D
Radiology; 2004 Jul; 232(1):58-65. PubMed ID: 15220493
[TBL] [Abstract][Full Text] [Related]
20. Myocardial uptake of 99mTc-tetrofosmin, sestamibi, and 201Tl in a model of acute coronary reperfusion.
Takahashi N; Reinhardt CP; Marcel R; Leppo JA
Circulation; 1996 Nov; 94(10):2605-13. PubMed ID: 8921807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]